| Literature DB >> 29881404 |
Behzad Sharif Makhmalzadeh1,2, Anayatollah Salimi1,2, Aida Niroomand2.
Abstract
Poor bioavailability of ophthalmic drops is mainly due to drainage through the nasal-lacrimal duct and a very low permeability through corneal epithelium. The aim of our study was to prepare and characterize an ocular hydrogel of loratadine, as an example of a lipophilic drug, to increase drug concentration and residence time at the site of action in the eye. In this study, a 23 full factorial design was employed to design and compare the properties of eight different loratadine containing hydrogel formulations. Results showed a significant correlation between the swelling and porosity ratios of the hydrogels and the Pluronic percentage and Pluronic/carbomer ratio in the formulations. Moreover, the release profiles showed fast and sustained release of all the formulations. Evaluation of hydrogels structure by the FT-IR technique indicated that Pluronic interacts with hydroxyl and carboxylic groups in carbomer, which is the main reason of the hydrogel network formation and interacts with loratadine.The permeation of loratadine through rabbit cornea showed that drug permeation percentages for the F2 and F7 formulations were 15 and 70 folds more than that of the control.Entities:
Keywords: Corneal permeability; Hydrogel; Loratadine; Ocular drug delivery; Thermo-responsible
Year: 2018 PMID: 29881404 PMCID: PMC5985164
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Compositions of Selected Hydrogels of Loratadine, Swellingand Porosity Ratios and 24- h. Drug Released Percent (mean ± SD, n = 3).
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| F1 | + + + | 10 | 2.5 | 1.25 | 2 | 84.25 | 41.85±4.1 | 1.38±0.14 | 56.56±1.2 |
| F2 | + + - | 10 | 2.5 | 2.5 | 2 | 83 | 43.16±3.2 | 1.32±0.01 | 48.85±0.9 |
| F3 | + - - | 10 | 5 | 3 | 2 | 80 | 37.58±1.3 | 1.48±0.33 | 41.03±1.1 |
| F4 | + - + | 10 | 5 | 1.5 | 2 | 81.5 | 35.1±1.7 | 1.35±0.11 | 58.87±1.3 |
| F5 | - + - | 5 | 1.25 | 1.25 | 2 | 90.5 | 37.15±3.8 | 0.15±0.02 | 78.41±1.6 |
| F6 | - + + | 5 | 1.25 | 0.625 | 2 | 91.125 | 44.92±3.9 | 0.078±0.01 | 17.36±0.8 |
| F7 | - - + | 5 | 2.5 | 0.75 | 2 | 90.75 | 68.66±3.5 | 0.033±0.04 | 98.9±1.2 |
| F8 | - - - | 5 | 2.5 | 1.5 | 2 | 89 | 33.14±3.6 | 0.64±0.1 | 76.85±1.4 |
Figure 1Swelling ratio of hydrogels as a function of time at 37 °C
Figure 2DSC thermograms of loratadine, cornea and cornea treated with loratadine loaded – hydrogel.
Figure 3FT-IR spectra of the prepared hydrogel formulations
Figure 4Drug release profiles through hydrogel formulations
Figure 5SEM images of hydrogel F7
Figure 6In-vitro Permeation profiles of Loratadine hydrogel (F2, F7) through rabbit cornea after 5 h.